1
|
Apinda N, Yao Y, Zhang Y, Muenthaisong A, Sangkakam K, Nambooppha B, Rittipornlertrak A, Koonyosying P, Nair V, Sthitmatee N. Efficiency of NHEJ-CRISPR/Cas9 and Cre-LoxP Engineered Recombinant Turkey Herpesvirus Expressing Pasteurella multocida OmpH Protein for Fowl Cholera Prevention in Ducks. Vaccines (Basel) 2023; 11:1498. [PMID: 37766174 PMCID: PMC10535566 DOI: 10.3390/vaccines11091498] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2023] [Revised: 09/12/2023] [Accepted: 09/13/2023] [Indexed: 09/29/2023] Open
Abstract
Fowl cholera is caused by the bacterium Pasteurella multocida, a highly transmissible avian ailment with significant global implications, leading to substantial economic repercussions. The control of fowl cholera outbreaks primarily relies on vaccination using traditional vaccines that are still in use today despite their many limitations. In this research, we describe the development of a genetically engineered herpesvirus of turkeys (HVT) that carries the OmpH gene from P. multocida integrated into UL 45/46 intergenic region using CRISPR/Cas9-NHEJ and Cre-Lox system editing. The integration and expression of the foreign cassettes were confirmed using polymerase chain reaction (PCR), indirect immunofluorescence assays, and Western blot assays. The novel recombinant virus (rHVT-OmpH) demonstrated stable integration of the OmpH gene even after 15 consecutive in vitro passages, along with similar in vitro growth kinetics as the parent HVT virus. The protective efficacy of the rHVT-OmpH vaccine was evaluated in vaccinated ducks by examining the levels of P. multocida OmpH-specific antibodies in serum samples using ELISA. Groups of ducks that received the rHVT-OmpH vaccine or the rOmpH protein with Montanide™ (SEPPIC, Paris, France) adjuvant exhibited high levels of antibodies, in contrast to the negative control groups that received the parental HVT or PBS. The recombinant rHVT-OmpH vaccine also provided complete protection against exposure to virulent P. multocida X-73 seven days post-vaccination. This outcome not only demonstrates that the HVT vector possesses many characteristics of an ideal recombinant viral vaccine vector for protecting non-chicken hosts, such as ducks, but also represents significant research progress in identifying a modern, effective vaccine candidate for combatting ancient infectious diseases.
Collapse
Affiliation(s)
- Nisachon Apinda
- Laboratory of Veterinary Vaccine and Biological Products, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (N.A.); (A.M.); (K.S.); (B.N.); (A.R.); (P.K.)
| | - Yongxiu Yao
- The Pirbright Institute, Woking GU24 0NF, UK; (Y.Y.); (Y.Z.); (V.N.)
| | - Yaoyao Zhang
- The Pirbright Institute, Woking GU24 0NF, UK; (Y.Y.); (Y.Z.); (V.N.)
| | - Anucha Muenthaisong
- Laboratory of Veterinary Vaccine and Biological Products, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (N.A.); (A.M.); (K.S.); (B.N.); (A.R.); (P.K.)
- Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Kanokwan Sangkakam
- Laboratory of Veterinary Vaccine and Biological Products, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (N.A.); (A.M.); (K.S.); (B.N.); (A.R.); (P.K.)
| | - Boondarika Nambooppha
- Laboratory of Veterinary Vaccine and Biological Products, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (N.A.); (A.M.); (K.S.); (B.N.); (A.R.); (P.K.)
| | - Amarin Rittipornlertrak
- Laboratory of Veterinary Vaccine and Biological Products, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (N.A.); (A.M.); (K.S.); (B.N.); (A.R.); (P.K.)
| | - Pongpisid Koonyosying
- Laboratory of Veterinary Vaccine and Biological Products, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (N.A.); (A.M.); (K.S.); (B.N.); (A.R.); (P.K.)
- Office of Research Administration, Chiang Mai University, Chiang Mai 50200, Thailand
| | - Venugopal Nair
- The Pirbright Institute, Woking GU24 0NF, UK; (Y.Y.); (Y.Z.); (V.N.)
- Jenner Institute, University of Oxford, Oxford OX1 2JD, UK
- Department of Biology, University of Oxford, Oxford OX1 3SZ, UK
| | - Nattawooti Sthitmatee
- Laboratory of Veterinary Vaccine and Biological Products, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50200, Thailand; (N.A.); (A.M.); (K.S.); (B.N.); (A.R.); (P.K.)
| |
Collapse
|
2
|
Shah AU, Wang Z, Zheng Y, Guo R, Chen S, Xu M, Zhang C, Liu Y, Wang J. Construction of a Novel Infectious Clone of Recombinant Herpesvirus of Turkey Fc-126 Expressing VP2 of IBDV. Vaccines (Basel) 2022; 10:vaccines10091391. [PMID: 36146468 PMCID: PMC9501487 DOI: 10.3390/vaccines10091391] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/05/2022] [Revised: 08/19/2022] [Accepted: 08/22/2022] [Indexed: 11/23/2022] Open
Abstract
The increased virulence of infectious bursal disease virus (IBDV) is a threat to the chicken industry. The construction of novel herpesvirus of turkey-vectored (HVT) vaccines expressing VP2 of virulent IBDV may be a promising vaccine candidate for controlling this serious disease in chickens. We generated a novel infectious clone of HVT Fc-126 by inserting mini-F sequences in lieu of the glycoprotein C (gC) gene. Based on this bacterial artificial chromosome (BAC), a VP2 expression cassette containing the pMCMV IE promoter and a VP2 sequence from the virulent IBDV NJ09 strain was inserted into the noncoding area between the UL55 and UL56 genes to generate the HVT vector VP2 recombinant, named HVT-VP2-09. The recovered vectored mutant HVT-VP2-09 exhibited higher titers (p = 0.0202 at 36 h) or similar growth kinetics to the parental virus HVT Fc-126 (p = 0.1181 at 48 h and p = 0.1296 at 64 h). The high reactivation ability and strong expression of VP2 by HVT-VP2-09 in chicken embryo fibroblasts (CEFs) were confirmed by indirect immunofluorescence (IFA) and Western blotting. The AGP antibodies against IBDV were detected beginning at 3 weeks post-inoculation (P.I.) of HVT-VP2-09 in 1-day-old SPF chickens. Seven of ten chickens immunized with HVT-VP2-09 were protected post-challenge (P.C.) with the virulent IBDV NJ09 strain. In contrast, all chickens in the challenge control group showed typical IBD lesions in bursals, and eight of ten died P.C. In this study, we demonstrated that (i) a novel HVT BAC with the whole genome of the Fc-126 strain was obtained with the insertion of mini-F sequences in lieu of the gC gene; (ii) HVT-VP2-09 harboring the VP2 expression cassette from virulent IBDV exhibited in vitro growth properties similar to those of the parental HVT virus in CEF cells; and (iii) HVT-VP2-09 can provide efficient protection against the IBDV NJ09 strain.
Collapse
Affiliation(s)
- Abid Ullah Shah
- National Research Center of Engineering and Technology for Veterinary Biologicals/Institute of Veterinary Immunology and Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal, Infectious Diseases and Zoonoses, Yangzhou 225009, China
- Jiangsu Key Laboratory of Food Quality and Safety, State Key Laboratory Cultivation Base of MOST, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
| | - Zhisheng Wang
- National Research Center of Engineering and Technology for Veterinary Biologicals/Institute of Veterinary Immunology and Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal, Infectious Diseases and Zoonoses, Yangzhou 225009, China
- Jiangsu Key Laboratory of Food Quality and Safety, State Key Laboratory Cultivation Base of MOST, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
| | - Yating Zheng
- National Research Center of Engineering and Technology for Veterinary Biologicals/Institute of Veterinary Immunology and Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal, Infectious Diseases and Zoonoses, Yangzhou 225009, China
| | - Rongli Guo
- Institute of Veterinary Medicine, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
| | - Saisai Chen
- National Research Center of Engineering and Technology for Veterinary Biologicals/Institute of Veterinary Immunology and Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal, Infectious Diseases and Zoonoses, Yangzhou 225009, China
| | - Mengwei Xu
- National Research Center of Engineering and Technology for Veterinary Biologicals/Institute of Veterinary Immunology and Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal, Infectious Diseases and Zoonoses, Yangzhou 225009, China
| | - Chuanjian Zhang
- National Research Center of Engineering and Technology for Veterinary Biologicals/Institute of Veterinary Immunology and Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal, Infectious Diseases and Zoonoses, Yangzhou 225009, China
| | - Yamei Liu
- National Research Center of Engineering and Technology for Veterinary Biologicals/Institute of Veterinary Immunology and Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal, Infectious Diseases and Zoonoses, Yangzhou 225009, China
| | - Jichun Wang
- National Research Center of Engineering and Technology for Veterinary Biologicals/Institute of Veterinary Immunology and Engineering, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, China
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal, Infectious Diseases and Zoonoses, Yangzhou 225009, China
- Correspondence: ; Tel.: +86-25-84395605
| |
Collapse
|
3
|
Towards Improved Use of Vaccination in the Control of Infectious Bronchitis and Newcastle Disease in Poultry: Understanding the Immunological Mechanisms. Vaccines (Basel) 2021; 9:vaccines9010020. [PMID: 33406695 PMCID: PMC7823560 DOI: 10.3390/vaccines9010020] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Revised: 12/24/2020] [Accepted: 12/29/2020] [Indexed: 12/11/2022] Open
Abstract
Infectious bronchitis (IB) and Newcastle disease (ND) are two important diseases of poultry and have remained a threat to the development of the poultry industry in many parts of the world. The immunology of avian has been well studied and numerous vaccines have been developed against the two viruses. Most of these vaccines are either inactivated vaccines or live attenuated vaccines. Inactivated vaccines induce weak cellular immune responses and require priming with live or other types of vaccines. Advanced technology has been used to produce several types of vaccines that can initiate prime immune responses. However, as a result of rapid genetic variations, the control of these two viral infections through vaccination has remained a challenge. Using various strategies such as combination of live attenuated and inactivated vaccines, development of IB/ND vaccines, use of DNA vaccines and transgenic plant vaccines, the problem is being surmounted. It is hoped that with increasing understanding of the immunological mechanisms in birds that are used in fighting these viruses, a more successful control of the diseases will be achieved. This will go a long way in contributing to global food security and the economic development of many developing countries, given the role of poultry in the attainment of these goals.
Collapse
|
4
|
Tatár-Kis T, Fischer EA, Cazaban C, Walkó-Kovács E, Homonnay ZG, Velkers FC, Palya V, Stegeman JA. A Herpesvirus of Turkey-Based Vector Vaccine Reduces Transmission of Newcastle Disease Virus in Commercial Broiler Chickens with Maternally Derived Antibodies. Vaccines (Basel) 2020; 8:vaccines8040614. [PMID: 33081359 PMCID: PMC7720113 DOI: 10.3390/vaccines8040614] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2020] [Revised: 10/08/2020] [Accepted: 10/13/2020] [Indexed: 12/28/2022] Open
Abstract
Newcastle Disease is one of the most important infectious poultry diseases worldwide and is associated with high morbidity, mortality, and economic loss. In several countries, vaccination is applied to prevent and control outbreaks; however, information on the ability of vaccines to reduce transmission of ND virus (NDV) is sparse. Here we quantified the transmission of velogenic NDV among 42-day-old broilers. Chickens were either vaccinated with a single dose of a vector vaccine expressing the F protein (rHVT-ND) at day-old in the presence of maternally derived antibodies or kept unvaccinated. Seeders were challenged 8 h before the co-mingling with the corresponding contacts from the same group. Infection was monitored by daily testing of cloacal and oro-nasal swabs with reverse transcription-real-time PCR and by serology. Vaccinated birds were completely protected against clinical disease and virus excretion was significantly reduced compared to the unvaccinated controls that all died during the experiment. The reproduction ratio, which is the average number of secondary infections caused by an infectious bird, was significantly lower in the vaccinated group (0.82 (95% CI 0.38-1.75)) than in the unvaccinated group (3.2 (95% CI 2.06-4.96)). Results of this study demonstrate the potential of rHVT-ND vaccine in prevention and control of ND outbreaks.
Collapse
Affiliation(s)
- Timea Tatár-Kis
- Scientific Support and Investigation Unit, Ceva-Phylaxia, 1107 Budapest, Hungary; (T.T.-K.); (E.W.-K.); (Z.G.H.); (V.P.)
| | - Egil A.J. Fischer
- Population Health Department, Veterinary Medicine Faculty, Utrecht University, 3584 CL Utrecht, The Netherlands; (E.A.J.F.); (F.C.V.)
| | - Christophe Cazaban
- Science and Investigation Department, Ceva Animal Health, 33500 Libourne, France;
| | - Edit Walkó-Kovács
- Scientific Support and Investigation Unit, Ceva-Phylaxia, 1107 Budapest, Hungary; (T.T.-K.); (E.W.-K.); (Z.G.H.); (V.P.)
| | - Zalan G. Homonnay
- Scientific Support and Investigation Unit, Ceva-Phylaxia, 1107 Budapest, Hungary; (T.T.-K.); (E.W.-K.); (Z.G.H.); (V.P.)
| | - Francisca C. Velkers
- Population Health Department, Veterinary Medicine Faculty, Utrecht University, 3584 CL Utrecht, The Netherlands; (E.A.J.F.); (F.C.V.)
| | - Vilmos Palya
- Scientific Support and Investigation Unit, Ceva-Phylaxia, 1107 Budapest, Hungary; (T.T.-K.); (E.W.-K.); (Z.G.H.); (V.P.)
| | - J. Arjan Stegeman
- Population Health Department, Veterinary Medicine Faculty, Utrecht University, 3584 CL Utrecht, The Netherlands; (E.A.J.F.); (F.C.V.)
- Correspondence:
| |
Collapse
|
5
|
Rauw F, Ngabirano E, Gardin Y, Palya V, Lambrecht B. Effectiveness of a Simultaneous rHVT-F(ND) and rHVT-H5(AI) Vaccination of Day-Old Chickens and the Influence of NDV- and AIV-Specific MDA on Immune Response and Conferred Protection. Vaccines (Basel) 2020; 8:vaccines8030536. [PMID: 32948028 PMCID: PMC7565404 DOI: 10.3390/vaccines8030536] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2020] [Revised: 09/10/2020] [Accepted: 09/11/2020] [Indexed: 11/16/2022] Open
Abstract
The recombinant herpesvirus of turkey (rHVT) vaccines targeting Newcastle disease (ND) and H5Nx avian influenza (AI) have been demonstrated efficient in chickens when used individually at day-old. Given the practical field constraints associated with administering two vaccines separately and in the absence of a currently available bivalent rHVT vector vaccine expressing both F(ND) and H5(AI) antigens, the aim of this study was to investigate whether interference occurs between the two vaccines when simultaneously administered in a single shot. The studies have been designed to determine (i) the ND and AI-specific protection and antibody response conferred by these vaccines inoculated alone or in combination at day-old, (ii) the influence of maternally-derived antibodies (MDA), and (iii) the potential interference between the two vaccine. Our results demonstrate that their combined administration is efficient to protect chickens against clinical signs of velogenic Newcastle disease virus (vNDV) and H5-highly pathogenic avian influenza virus (HPAIV) infections. Viral shedding following co-vaccination is also markedly reduced, while slightly lower NDV- and AIV-specific antibody responses are observed. NDV- and AIV-specific MDA show negative effects on the onset of the specific antibody responses. However, if AIV-specific MDA reduce the protection against H5-HPAIV induced by rHVT-H5(AI) vaccine, it was not observed for ND.
Collapse
Affiliation(s)
- Fabienne Rauw
- Sciensano, Avian Virology and Immunology Service, Groeselenberg 99, 1180 Brussels, Belgium; (E.N.); (B.L.)
- Correspondence:
| | - Eva Ngabirano
- Sciensano, Avian Virology and Immunology Service, Groeselenberg 99, 1180 Brussels, Belgium; (E.N.); (B.L.)
| | - Yannick Gardin
- CEVA Santé Animale, Avenue de la Ballastière 10, 33 500 Libourne, France;
| | - Vilmos Palya
- CEVA Phylaxia, Szállás utca 5, 1107 Budapest, Hungary;
| | - Bénédicte Lambrecht
- Sciensano, Avian Virology and Immunology Service, Groeselenberg 99, 1180 Brussels, Belgium; (E.N.); (B.L.)
| |
Collapse
|
6
|
Soleimani Roudi P, Golian A, Haghparast A, Bassami MR, Majidzadeh Heravi R. Effect of adjuvants on in ovo vaccination against Newcastle disease on hatchability, performance and antibody titres in commercial pullets. J Anim Physiol Anim Nutr (Berl) 2018; 102:977-985. [DOI: 10.1111/jpn.12903] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2017] [Accepted: 03/23/2018] [Indexed: 01/19/2023]
Affiliation(s)
- P. Soleimani Roudi
- Faculty of Agriculture; Department of Animal Sciences; Ferdowsi University of Mashhad; Mashhad Iran
| | - A. Golian
- Faculty of Agriculture; Department of Animal Sciences; Ferdowsi University of Mashhad; Mashhad Iran
| | - A. Haghparast
- Faculty of Veterinary Medicine; Department of Pathobiology; Ferdowsi University of Mashhad; Mashhad Iran
| | - M. R. Bassami
- Faculty of Veterinary Medicine; Department of Clinical Sciences; Ferdowsi University of Mashhad; Mashhad Iran
| | - R. Majidzadeh Heravi
- Faculty of Agriculture; Department of Animal Sciences; Ferdowsi University of Mashhad; Mashhad Iran
| |
Collapse
|
7
|
Rauw F, Nguyen TG, Ngabirano E, Marché S, Lambrecht B. Specific antibody-mediated immunity in the reproductive tract of laying chickens immunized against Newcastle disease with conventional attenuated and inactivated vaccines. Avian Pathol 2017; 46:434-441. [PMID: 28290220 DOI: 10.1080/03079457.2017.1304528] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Despite the widespread and successful use of Newcastle disease (ND) vaccines, Newcastle disease virus (NDV) can seriously injure the reproductive tract of egg-laying hens, leading to rapid egg-drop and poor shell quality. Few published studies investigated local NDV-specific immune response in the reproductive tract after ND vaccination of hens. The present study investigated, for the first time, local NDV-specific antibody-mediated immunity in segments of the oviduct during the laying period. Specific pathogen-free (SPF) White Leghorn chickens were immunized following an ND vaccination programme applied in the field, which combined ND-attenuated vaccine (inoculated subcutaneously at one day, 2 weeks and 11 weeks of age) with inactivated vaccine (inoculated intramuscularly at 17 weeks). The infundibulum, magnum, isthmus and uterus (segments of the reproductive tract) were harvested at 28 weeks and 32 weeks of age (during the laying period). Supernatant from ex vivo tissue culture was collected and tested by: (i) haemagglutination inhibition (HI) test, (ii) commercial IDVet ND-enzyme-linked immunosorbent assay (ELISA) and (iii) NDV-specific IgG, IgM and IgA in-house ELISAs. For all sampling time points and oviduct segments, all samples were positive for commercial ND-ELISA and in-house ELISA-IgG. However, six of these ELISA-IgG positive samples yielded negative results when submitted to the HI test. Interestingly, NDV-specific IgM and IgA were detected frequently in the infundibulum and magnum as compared to the isthmus and uterus. These results show that the antibody immune response in the oviduct was induced by the timing of attenuated and inactivated ND vaccinations.
Collapse
Affiliation(s)
- F Rauw
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| | - T G Nguyen
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| | - E Ngabirano
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| | - S Marché
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| | - B Lambrecht
- a Avian Virology and Immunology Unit , Veterinary and Agrochemical Research Centre (VAR) , Ukkel (Brussels) , Belgium
| |
Collapse
|
8
|
Ingrao F, Rauw F, van den Berg T, Lambrecht B. Characterization of two recombinant HVT-IBD vaccines by VP2 insert detection and cell-mediated immunity after vaccination of specific pathogen-free chickens. Avian Pathol 2017; 46:289-299. [PMID: 27897452 DOI: 10.1080/03079457.2016.1265083] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
Infectious bursal disease (IBD) is an avian viral disease that causes severe economic losses in the poultry industry worldwide. The live IBD virus (IBDV) has a potential immunosuppressive effect. Currently available IBDV vaccines have shortcomings, prompting the development of safer and more effective vaccination approaches, including the use of the recombinant turkey herpesvirus vaccine expressing the immunogenic structural VP2 protein of IBDV (recombinant HVT (rHVT)-IBD). The objectives of this study were twofold: (i) to develop in vitro assays and molecular tools to detect the VP2 protein and gene and (ii) to evaluate cell-mediated immunity (CMI) induced by rHVT-IBD vaccination of day-old specific pathogen-free chickens. The VP2 protein expressed by rHVT-IBD-infected chicken embryo fibroblasts was detected using the enzyme-linked immunosorbent assay and immunofluorescence. Using molecular techniques, the VP2 gene was detected in various organs, providing a method to monitor vaccine uptake. rHVT-IBD vaccination induced CMI responses in specific pathogen-free chickens at 5 weeks. CMI was detected by measuring chicken interferon-gamma after ex vivo antigenic stimulation of splenocytes. Moreover, our results showed that the enzyme-linked immunospot approach is more sensitive in detecting chicken interferon-gamma than enzyme-linked immunosorbent assay. The tools developed in this study may be useful in the characterization of new-generation recombinant vaccines and the cellular immune response they induce.
Collapse
Affiliation(s)
- Fiona Ingrao
- a Avian Virology & Immunology Unit , Veterinary and Agrochemical Research Centre , Brussels , Belgium
| | - Fabienne Rauw
- a Avian Virology & Immunology Unit , Veterinary and Agrochemical Research Centre , Brussels , Belgium
| | - Thierry van den Berg
- a Avian Virology & Immunology Unit , Veterinary and Agrochemical Research Centre , Brussels , Belgium
| | - Bénédicte Lambrecht
- a Avian Virology & Immunology Unit , Veterinary and Agrochemical Research Centre , Brussels , Belgium
| |
Collapse
|
9
|
Palya V, Kovács EW, Tatár-Kis T, Felföldi B, Homonnay ZG, Mató T, Sato T, Gardin Y. Recombinant Turkey Herpesvirus-AI Vaccine Virus Replication in Different Species of Waterfowl. Avian Dis 2016; 60:210-7. [DOI: 10.1637/11129-050715-reg] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
10
|
Rauw F, Van Borm S, Welby S, Ngabirano E, Gardin Y, Palya V, Lambrecht B. Quantification of rHVT-F genome load in feather follicles by specific real-time qPCR as an indicator of NDV-specific humoral immunity induced by day-old vaccination in SPF chickens. Avian Pathol 2015; 44:154-61. [PMID: 25687165 DOI: 10.1080/03079457.2015.1018869] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Abstract
The purpose of this study was to look for a reliable molecular method for confirmation of uptake of recombinant turkey herpesvirus vaccine against Newcastle disease (rHVT-F) and for use as a valuable prediction tool of Newcastle disease virus (NDV)-specific immune response in chickens deprived of maternally derived antibody (MDA). A quantitative real-time polymerase chain reaction (real-time qPCR) specific to rHVT-F was developed. The method was applied to various tissue samples taken from specific pathogen free (SPF) chickens experimentally inoculated at day-old with one dose of rHVT-F vaccine over a 6-week period. Among the tested tissues, the rHVT-F vaccine was detected predominantly in the bursa of Fabricius (BF) and the lung for the first week, followed by a progressive decline from 9 days onwards. Then, an increase of genome load was observed in the feather follicles (FF) with a peak at 2 weeks, rising to a level almost 10(3)-fold greater than in the other tissues. Importantly, the rHVT-F genome load in FF appeared to be strongly correlated to the humoral immunity specific to NDV as evaluated by haemagglutination inhibition (HI) test and NDV-specific IgG, IgM and IgA ELISAs. This is the first report of quantification of rHVT-F vaccine in FF and its correlation with the induction of ND-specific immune response in chickens with no MDA. Our data indicate that the application of this real-time qPCR assay on FF samples taken from chickens in the field may be used to confirm rHVT-F vaccine administration and uptake with the important added benefit of offering a non-disruptive sampling procedure.
Collapse
Affiliation(s)
- F Rauw
- a Veterinary and Agrochemical Research Centre (VAR) , Ukkel , Belgium
| | | | | | | | | | | | | |
Collapse
|